RAPIBLOC 20mg/2ml concentrate for solution for injection AMOMED
landiolol Indicated for: cardiac arrhythmias
letter R · page 9
landiolol Indicated for: cardiac arrhythmias
landiolol Indicated for: cardiac arrhythmias
landiolol Indicated for: cardiac arrhythmias
reteplase Indicated for: thrombolysis; myocardial infarction; ischemic stroke
B01AD07 Blood and blood forming organs | Antithrombotic agents | Antithrombotic agents | Enzymes
regadenosone Indicated for: pharmacologic stress test for myocardial perfusion
diclofenac Indicated for: pain and inflammation
diclofenac Indicated for: pain and inflammation
efalizumab Indicated for: psoriasis
rasagiline Indicated for: Parkinson's disease
N04BD02 Nervous system | Dopaminergic agents | Monoamine oxidase B inhibitors
rasagiline Indicated for: Parkinson's disease
N04BD02 Nervous system | Dopaminergic agents | Monoamine oxidase B inhibitors
rasagiline Indicated for: Parkinson's disease
N04BD02 Nervous system | Dopaminergic agents | Monoamine oxidase B inhibitors
rasagiline Indicated for: Parkinson's disease
N04BD02 Nervous system | Dopaminergic agents | Monoamine oxidase B inhibitors
rasagiline Indicated for: Parkinson's disease
N04BD02 Nervous system | Dopaminergic agents | Monoamine oxidase B inhibitors
rasagiline Indicated for: Parkinson's disease
N04BD02 Nervous system | Dopaminergic agents | Monoamine oxidase B inhibitors
rasagiline Indicated for: Parkinson's disease
N04BD02 Nervous system | Dopaminergic agents | Monoamine oxidase B inhibitors
rasagiline Indicated for: Parkinson's disease
N04BD02 Nervous system | Dopaminergic agents | Monoamine oxidase B inhibitors
rasagiline Indicated for: Parkinson's disease
N04BD02 Nervous system | Dopaminergic agents | Monoamine oxidase B inhibitors
rasagiline Indicated for: Parkinson's disease
N04BD02 Nervous system | Dopaminergic agents | Monoamine oxidase B inhibitors
rasagiline Indicated for: Parkinson's disease
N04BD02 Nervous system | Dopaminergic agents | Monoamine oxidase B inhibitors
rasagiline Indicated for: Parkinson's disease
N04BD02 Nervous system | Dopaminergic agents | Monoamine oxidase B inhibitors